Thousands with advanced breast cancer could live long lives thanks to a new drug approved on the NHS . Capivasertib, retailed ...

Professor Nicholas Turner, from the Institute of Cancer Research, tells Sky News that capivasertib is a "great success story ...

Capivasertib is taken as a twice-daily pill, in combination with the hormone therapy fulvestrant. The drug works by blocking ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

The National Institute for Health and Care Excellence (NICE) has approved the use of the tablet capivasertib, in combination with fulvestrant, for patients with hormone receptor-positive, ...

AstraZeneca’s Truqap (capivasertib) has been approved for use by the National Health Service (NHS) in England and Wales, ...

Today, we've recommended capivasertib (also called Truqap and made by AstraZeneca) with fulvestrant as an option for around 1,100 adults with hormone receptor (HR)-positive HER2-negative breast cancer ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

The United Kingdom’s National Institute for Health and Care Excellence (NICE) has approved a “game-changing” twice-a-day pill ...

A breakthrough cancer drug for those facing the advanced stages of the disease has been approved for the first time on the ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...

Discover how cancer treatments impact heart health and learn strategies to mitigate cardiovascular risks during and after ...